They unveil that LINC00942 (LNC942) exerts its functions as an oncogene in promoting METTL14-mediated m6A modification and regulates the expression and stability of LNC942 downstream target genes C-X-C motif chemokine receptor 4 (CXCR4) and cytochrome P450 1B1 gene (CYP1B1) in breast cancer initiation and progression. The gene discussed is METTL14; the disease is breast carcinoma.